Arvind Remedies establishes Rs 250-crore manufacturing facility near Chennai

26 Jun 2013 Evaluate

Arvind Remedies has established an Rs 250-crore manufacturing facility at Irungattukottai, near Chennai, in order to tap the US market. It has begun with testing and development of analgesic and cardiac generic drugs (tablets) at the plant, which will seek USFDA approval in next six months.

The company has also established a subsidiary in New Jersey to take care of its US strategy. It is likely to distribute its drugs in the US and also get into contract manufacturing for other American pharma companies.

 

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×